CD19 and melanoma: CD38&lt;sup&gt;hi&lt;/sup&gt;CD19&lt;sup&gt;dim&lt;/sup&gt; cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade.